SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lupus drug combo trial aims to match treatments to immune profiles
Disease control TerminatedThis study tested two lupus medications—mycophenolate mofetil alone or with voclosporin—in 12 adults with moderate-to-severe lupus. The goal was to see if grouping patients by their immune system type could predict who responds best. The trial was stopped early, but the data may …
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 01, 2026 15:39 UTC
-
Lupus drug trial halted early: what we know about telitacicept
Disease control TerminatedThis study tested a drug called telitacicept in people with moderate-to-severe lupus, an autoimmune disease that causes inflammation and organ damage. The goal was to see if the drug could reduce lupus activity and allow lower steroid use. The trial was stopped early, and results…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC